Skip to content

Verification of intestinal environment improvement by amazake intake

Verification of intestinal environment improvement by amazake intake - Verification of intestinal environment improvement by amazake intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038323
Enrollment
20
Registered
2019-10-18
Start date
2019-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Amazake made by rice koji is taken once a day for 4 weeks Placebo drink of control 1 is taken once a day for 4 weeks Amazake made by rice koji and sake lees is taken once a day for 4 weeks Placebo dri

Sponsors

MORINAGA & CO., LTD.
Lead Sponsor
Matsuike Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Regular visitor of Matsuo Clinic 2) Women with mild constipation who are prescribed magnesium oxide whose age at the time of obtaining consent to participate in the study is 20 to 60 years old (20 to 60 years old) 3) Those who have received sufficient explanation about the purpose and content of this study, have the ability to consent, volunteered to participate voluntarily after understanding well, and can agree to participate in this study in writing 4) Those who can visit the hospital on the designated day and can receive an inquiry 5) Those who are deemed appropriate by the study investigator to participate in this study

Exclusion criteria

Exclusion criteria: 1) Persons with symptoms other than mild constipation 2) Persons who have no visit history for the past 3 months 3) Those who cannot be judged by the investigator without affecting the participation in the study 4) Those who may cause allergic symptoms to ingredients in test food 5) People who drink amazake (regardless of manufacturer) 6) Those who plan to become pregnant, breast-feeding, or possibly pregnant, and pregnant during the study period 7) Persons with alcoholism or other mental disorders 8) Persons who may change their lifestyle during the test period (night work, long trip, etc.) 9) Those who are planning to take health functional foods or supplement foods during the study period 10) Those who have been treated with hospitalization within the past 6 months 11) Persons currently participating in other human clinical trials, those who have not passed 3 months since participating in other human clinical trials 12) Other persons who are deemed inappropriate by the study investigator

Design outcomes

Primary

MeasureTime frame
alteration of intensional bacterial flora

Secondary

MeasureTime frame
Bowel movement

Countries

Japan

Contacts

Public Contactsadao mori

MORINAGA & CO., LTD. R & D Center

s-mori-ab@morinaga.co.jp045-571-6140

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026